Northern Blotting Market Outlook:
Northern Blotting Market size was valued at USD 421.3 million in 2024 and is projected to reach USD 862.3 million by the end of 2037, registering around 5.8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of the northern blotting is assessed at 442.4 million.
The northern blotting market is expanding steadily and is particularly driven by a rise in demand for academic, government, and clinical research institutions. The patient’s utilizing transcriptomic diagnostics through northern blotting is concerted in neurogenetic, oncology, and infectious disease programs. As per the NIH report, nearly USD 3.7 billion was allocated for gene expression and transcriptomic research programs in 2023 under NIH’s Molecular and Cellular Biology Portfolio. CIHI and Health Canada state that almost 620,010 patients in 2023 were managed using blotting diagnostics, especially in oncology and rare disease research. This reflects increasing reliance on the public sector on blotting-related technologies in the population screening process.
On the basis of the supply chain, the northern blotting market depends on the polyacrylamide membranes, electrophoresis devices, isotope-labeled RNA probes, and precision reagents. Europe and Japan export a large number of reagents and high-grade chemicals to the U.S. Moreover, the report from the U.S. Census Bureau states that nearly USD 278.9 million reagents were imported from Germany and the UK. The transportation and supply chain of these temperature-sensitive materials has increased the pressure related to the cost, and the U.S. Bureau of Labor Statistics highlights a 5.8% increase in Producer Price Index (PPI) for laboratory instruments. On the other hand, the Consumer Price Index (CPI) rose by 4.1% for medical laboratory services.
